Japanese Pharmaceuticals & Biotech Big Green Snowflakes

Japan Tissue Engineering

Market Cap: JP¥20.1b

Engages in the regenerative medicine business in Japan.

Nippon Chemiphar

Market Cap: JP¥5.8b

Engages in the manufacture, sale, import, and export of ethical pharmaceuticals and diagnostic agents in Japan and internationally.

Modalis Therapeutics

Market Cap: JP¥6.1b

Engages in the research and development of therapeutics to treat patients with serious genetic disorders.

PeptiDream

Market Cap: JP¥196.6b

A biopharmaceutical company, engages in the discovery and development of constrained peptides, small molecules, and peptide-drug conjugate therapeutics.

Chordia Therapeutics

Market Cap: JP¥8.9b

A biotech company, engages in research and development of anti-cancer drugs that targets RNA deregulation stress in Japan.

Astena Holdings

Market Cap: JP¥20.7b

Manufactures and sells medicine-related products in Japan.

Sumitomo Pharma

Market Cap: JP¥696.1b

Engages in manufacture, purchase, and sale of pharmaceutical products for medical treatment in Japan, North America, and Asia.

D. Western Therapeutics Institute

Market Cap: JP¥5.2b

A biotechnology company, focuses on discovery and development of various drugs.

Ribomic

Market Cap: JP¥4.2b

Ribomic Inc. discovers and develops pharmaceutical compounds using RNA aptamers in Japan.

TMS

Market Cap: JP¥6.8b

Engages in the research and development, manufacture, and sale of drug products, quasi-drugs, drug substances, medical devices, and medical commodities.

Carna Biosciences

Market Cap: JP¥3.9b

A clinical-stage biopharmaceutical company, discovers and develops drug therapies to treat unmet medical needs in Japan.

Pharma Foods International

Market Cap: JP¥23.3b

Engages in the development and sale of functional food ingredients in Japan.

JCR Pharmaceuticals

Market Cap: JP¥77.3b

Engages in the research, development, manufacture, import and export, and sale of pharmaceutical products, regenerative medicines, and drug substances in Japan.

Precision System Science

Market Cap: JP¥5.4b

Develops, manufactures, and sells automated systems/instruments, other physicochemical instruments, software, and other products.

FunPep

Market Cap: JP¥4.2b

Engages in the research and development of pharmaceuticals drugs, functional cosmetics, and medical devices based on functional peptides.

Renascience

Market Cap: JP¥20.0b

Engages in the development and commercialization of pharmaceuticals and medical devices in Japan.

Solasia Pharma K.K

Market Cap: JP¥9.7b

Engages in the development and marketing of oncology drugs in Japan and other Asian countries.

Kringle Pharma

Market Cap: JP¥3.1b

Engages in the research and development, manufactures, and sells hepatocyte growth factor (HGF) protein pharmaceuticals for regenerative medicines.

Cyfuse Biomedical K.K

Market Cap: JP¥5.0b

Engages in the development, manufacture, and sale of regenerative medicine products in Japan.

Delta-Fly Pharma

Market Cap: JP¥5.0b

Develops anticancer drugs.

Healios K.K

Market Cap: JP¥57.6b

Engages in the research and development, manufacture, and sale of cell therapy and regenerative medicine products in Japan, Europe, and the United States.

Seikagaku

Market Cap: JP¥35.6b

Manufactures and sells pharmaceuticals and medical devices primarily related to glycoconjugates in Japan and internationally.The company operates in two segments, Pharmaceuticals and LAL Business.

NANO MRNALtd

Market Cap: JP¥9.2b

Researches, develops, produces, and sells pharmaceuticals using micellar nanoparticles technology in Japan.

Veritas In Silico

Market Cap: JP¥4.5b

Engages in the business of small molecule drug discovery and nucleic acid drug discovery targeting mRNA.

MedRx

Market Cap: JP¥8.1b

A pharmaceutical formulation development company, provides pharmaceutical drugs based on the transdermal absorption system in Japan.

Heartseed

Market Cap: JP¥46.7b

Develops and commercializes iPS cell-derived cardiomyocyte replacement therapy for heart failure.

OncoTherapy Science

Market Cap: JP¥7.0b

Engages in research and development of anti-body drugs; and the genome analysis of cancer, liquid biopsy, and development of new immunotherapy in Japan.

StemRIM

Market Cap: JP¥18.3b

A biotechnology company, develops regeneration medicines for the treatment of intractable diseases.

Perseus Proteomics

Market Cap: JP¥4.6b

A drug discovery biotech venture company, develops antibody drugs against cancer and other diseases in Japan.

Kubota Pharmaceutical Holdings

Market Cap: JP¥3.7b

Develops portfolio of drugs and devices worldwide.

Cuorips

Market Cap: JP¥55.5b

Engages in the research, development, manufacture, commercialization, and sale of iPS cell-derived cardiomyocyte sheets.

Tsubota Laboratory

Market Cap: JP¥8.8b

Engages in the development and sale of pharmaceuticals and medical devices for the treatment of myopia, dry eyes, presbyopia, and neurological disorders.

AnGes

Market Cap: JP¥30.1b

Engages in the research and development of gene-based medical products.

SanBio

Market Cap: JP¥175.1b

Develops, produces, and sells regenerative cell medicines for the central nervous system.

RaQualia Pharma

Market Cap: JP¥13.7b

Engages in the research and development of pharmaceutical compounds worldwide.

ReproCELL

Market Cap: JP¥17.6b

Provides stem cell research and drug discovery services in Japan.